Key terms
About NCNA
NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NCNA news
Today
8:57am ET
NuCana Executes Reverse ADS Split to Boost Liquidity
Apr 09
5:29pm ET
NuCana Reveals NUC-7738’s Anti-Cancer Potential
Mar 28
8:16am ET
Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)
Mar 27
5:27pm ET
NuCana plc Announces Reverse ADS Split
Mar 27
4:38pm ET
NuCana to implemet ADS Ratio Change to one ADS representing twenty-five shares
Mar 24
8:16pm ET
Nucana (NCNA) Receives a Hold from TD Cowen
Mar 20
4:57pm ET
NuCana Plc Shows Positive Advances in Cancer Treatments
Mar 20
4:08pm ET
NuCana reports Q 4EPS (14c) vs.(29c) last year
Mar 15
11:32am ET
Biotech Alert: Searches spiking for these stocks today
Mar 14
11:01am ET
Biotech Alert: Searches spiking for these stocks today
No recent news articles are available for NCNA
No recent press releases are available for NCNA
NCNA Financials
Key terms
Ad Feedback
NCNA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NCNA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
